Local Access10 min readApril 9, 2026

    Buy Compounded Semaglutide in Houston: Telehealth vs Local Clinics (2026)

    Houston is one of the largest and most spread-out cities in America — and its weight loss clinic market reflects that scale with prices to match. Telehealth delivers compounded semaglutide to any Houston address for $99/month, without the clinic visit.

    Why Houston Residents Choose Telehealth for GLP-1

    Houston is home to the Texas Medical Center — the largest medical complex in the world — yet obesity remains a defining public health challenge for the city. Harris County's adult obesity rate consistently exceeds the national average, and the city's car-dependent layout means that reaching an in-person weight management clinic often requires a significant time investment. For residents in Humble, Pasadena, or Missouri City, a clinic visit in the Galleria can be a half-day ordeal.

    Houston also has a notably high rate of uninsured residents — approximately 22% of Harris County adults lack health insurance, among the highest rates of any major American city. For these residents, brand-name Wegovy at $1,000–$1,400 per month is simply out of reach, and even clinic-priced compounded semaglutide at $300–600/month is a stretch. Telehealth at $99/month changes the calculus entirely.

    Houston GLP-1 Snapshot

    Population: ~2.3 million city / ~7.3 million metro. Adult obesity rate: above national average. Uninsured rate: ~22% (Harris County). Typical clinic rate: $300–600/mo. Brand Wegovy: $1,000–$1,400/mo. TRIMI telehealth: $99/mo semaglutide, $125/mo tirzepatide.

    Type 2 diabetes is pervasive in Houston, with some zip codes in predominantly Hispanic communities in the East End and Northside recording diabetic prevalence rates among the highest in the country. GLP-1 medications were originally developed to treat type 2 diabetes and have since demonstrated powerful weight loss effects — meaning affordable access to these medications has both metabolic and cardiovascular implications for Houston residents.

    Local Clinic vs. Telehealth: Pricing Comparison

    Houston's weight loss clinic market spans upscale med-spas in River Oaks and the Galleria to functional medicine practices in The Woodlands and Sugar Land. Prices vary, but the clinic overhead model consistently produces costs that are two to six times higher than TRIMI's telehealth pricing.

    OptionMonthly CostIn-Person VisitInsurance Required
    Houston Weight Loss Clinic (avg)$300–$600YesSometimes
    Brand Wegovy (no insurance)$1,000–$1,400YesRecommended
    TRIMI Telehealth (compounded)$99/mo (sema) / $125/mo (tirz)NoNo

    How Telehealth Works: Consultation to Delivery in Houston

    Step 1: Online Health Intake

    Complete a comprehensive health questionnaire covering your medical history, current medications, BMI, and weight loss goals — from anywhere in the Houston metro area.

    Step 2: Texas Provider Review

    A licensed Texas provider evaluates your submission, confirms GLP-1 candidacy, and creates a dosing protocol starting at the lowest therapeutic dose.

    Step 3: Flat-Rate Prescription

    Your prescription is sent to a licensed compounding pharmacy. $99/mo for semaglutide or $125/mo for tirzepatide — no insurance, no prior authorization, no hidden fees.

    Step 4: Delivered to Your Door

    Temperature-controlled packaging arrives at your Houston address within 3–5 business days. Monthly refills ship automatically, and your provider manages dose adjustments online.

    Available Medications

    Compounded Semaglutide

    $99/month

    • Same active ingredient as Wegovy
    • Weekly self-injection
    • ~15% average weight loss at 68 weeks
    • No insurance required

    Compounded Tirzepatide

    $125/month

    • Dual GLP-1/GIP receptor agonist
    • Weekly self-injection
    • ~22% average weight loss at 72 weeks
    • No insurance required

    Unsure which medication fits your needs? Read the full semaglutide vs. tirzepatide comparison to understand the differences in efficacy, side effect profiles, and cost.

    Getting Started with TRIMI in Houston

    Houston residents with a BMI of 27 or higher (with at least one weight-related health condition) or a BMI of 30 or higher may be candidates for GLP-1 treatment through TRIMI. The entire process — from online intake to first delivery — takes approximately 3–5 business days.

    Whether you're in the Heights, Bellaire, Friendswood, or anywhere in the greater Houston area, TRIMI ships medication directly to your door. Learn more about whether you're a candidate for GLP-1 treatment, or check out our guide on how we ensure compounded medication safety.

    Ready to Start in Houston?

    Get compounded semaglutide delivered to any Houston address for $99/month. No office visit, no insurance, no waiting room.

    Get Started for $99/Month

    Medical Disclaimer

    This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. Harris County Public Health. Community Health Assessment: Obesity and Diabetes Prevalence. 2023.
    5. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 9, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Compare San Jose GLP-1 clinic pricing to Trimi's $99/mo telehealth semaglutide.

    Compare Columbus GLP-1 clinic pricing to Trimi's $99/mo telehealth semaglutide.

    Start your GLP-1 journey — from $99/mo

    Get Started